Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions
Mahmoud R. Hussein, Dalia Elsers, Sabah A. Fadel, et al.
Journal of Clinical Pathology (2006) Vol. 59, Iss. 3, pp. 316-324
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Melanocytic nevi and melanoma: unraveling a complex relationship
William Damsky, Marcus Bosenberg
Oncogene (2017) Vol. 36, Iss. 42, pp. 5771-5792
Open Access | Times Cited: 217
Tumor microenvironment and immunotherapy of oral cancer
Chang Liu, Min Wang, Haiyang Zhang, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 74
IgG4 subclass antibodies impair antitumor immunity in melanoma
Panagiotis Karagiannis, Amy E. Gilbert, Debra H. Josephs, et al.
Journal of Clinical Investigation (2013) Vol. 123, Iss. 4, pp. 1457-1474
Open Access | Times Cited: 197
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.
Darryl A. Oble, Robert Loewe, Ping Yu, et al.
PubMed (2009) Vol. 9, pp. 3-3
Closed Access | Times Cited: 186
Prognostic impact of B-cell density in cutaneous melanoma
Andrea Ladányi, Judit Kiss, Anita Mohos, et al.
Cancer Immunology Immunotherapy (2011) Vol. 60, Iss. 12, pp. 1729-1738
Open Access | Times Cited: 180
Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer
Jinru Shia, Destin Black, Amanda Hummer, et al.
Human Pathology (2007) Vol. 39, Iss. 1, pp. 116-125
Closed Access | Times Cited: 160
Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma
Andrea Ladányi
Pigment Cell & Melanoma Research (2015) Vol. 28, Iss. 5, pp. 490-500
Open Access | Times Cited: 154
Inflammation: A key process in skin tumorigenesis (Review)
Monica Neagu, Carolina Constantin, Constantin Căruntu, et al.
Oncology Letters (2018)
Open Access | Times Cited: 117
Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome
Kanika Garg, Margarita Maurer, Johannes Griss, et al.
Human Pathology (2016) Vol. 54, pp. 157-164
Closed Access | Times Cited: 97
Tumor infiltrating lymphocytes: The regulator of melanoma evolution (Review)
Mihaela Antohe, Roxana Nedelcu, Luciana Nichita, et al.
Oncology Letters (2019)
Open Access | Times Cited: 91
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies
Zena Willsmore, R. J. C. Harris, Silvia Crescioli, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 58
Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer
Chew Yee Ngan, Hirokazu Yamamoto, Iwao Seshimo, et al.
British Journal of Cancer (2007) Vol. 96, Iss. 6, pp. 986-992
Open Access | Times Cited: 145
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
Femke Hillen, Coen I.M. Baeten, Anouk van de Winkel, et al.
Cancer Immunology Immunotherapy (2007) Vol. 57, Iss. 1, pp. 97-106
Open Access | Times Cited: 117
PD-L1+ regulatory B cells act as a T cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis
Hao Wu, Liming Xia, Dong-Dong Jia, et al.
Molecular Immunology (2020) Vol. 119, pp. 83-91
Closed Access | Times Cited: 52
Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma
Vasileios Mourmouras, M. Biagioli, Clelia Miracco, et al.
Oncology Reports (2007)
Open Access | Times Cited: 91
Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA
Ralf Lutterbuese, Tobias Raum, Roman Kischel, et al.
Journal of Immunotherapy (2009) Vol. 32, Iss. 4, pp. 341-352
Closed Access | Times Cited: 76
Targeting CD20 in Melanoma Patients at High Risk of Disease Recurrence
Alice Pinc, Rajasekharan Somasundaram, Christine Wagner, et al.
Molecular Therapy (2012) Vol. 20, Iss. 5, pp. 1056-1062
Open Access | Times Cited: 74
B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment
Giulia Chiaruttini, Silvia Mele, James W. Opzoomer, et al.
OncoImmunology (2017) Vol. 6, Iss. 4, pp. e1294296-e1294296
Open Access | Times Cited: 59
Plasma cells in primary melanoma. Prognostic significance and possible role of IgA
Francesca Maria Bosisio, James S. Wilmott, Nathalie Volders, et al.
Modern Pathology (2016) Vol. 29, Iss. 4, pp. 347-358
Open Access | Times Cited: 51
Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review
Hassan Mesgari, Samar Esmaelian, Kamyar Nasiri, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5600-5600
Open Access | Times Cited: 14
Programmed Cell Death Ligand 1 Immunohistochemical Expression and Cutaneous Melanoma: A Controversial Relationship
Vincenzo Fiorentino, Cristina Pizzimenti, Mariausilia Franchina, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 676-676
Open Access | Times Cited: 5
Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations
Monica Neagu, Carolina Constantin, Sabina Zurac
BioMed Research International (2013) Vol. 2013, pp. 1-13
Open Access | Times Cited: 51
Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases
Vasileios Mourmouras, Michele Fimiani, Pietro Rubegni, et al.
British Journal of Dermatology (2007) Vol. 157, Iss. 3, pp. 531-539
Closed Access | Times Cited: 59
Microenvironment and tumor progression of melanoma: New therapeutic prospectives
Gerardo Botti, Margherita Cerrone, Giosuè Scognamiglio, et al.
Journal of Immunotoxicology (2012) Vol. 10, Iss. 3, pp. 235-252
Closed Access | Times Cited: 46
Association between natural killer cells and regression in melanocytic lesions
Kristopher McKay, Page C. Moore, Bruce R. Smoller, et al.
Human Pathology (2011) Vol. 42, Iss. 12, pp. 1960-1964
Closed Access | Times Cited: 45
Page 1 - Next Page

Scroll to top